Simulation Gives Clues About Forces Underlying Fundamental Cellular Processes
|
By LabMedica International staff writers Posted on 28 Apr 2014 |

Image: Cell-like features in computer simulated active droplets: Left – static distortion; Middle – motility; Right: division (Photo courtesy of Dr. Luca Giomi and Dr. Antonio DeSimone, SISSA).
Researchers have developed a simulation model resulting in clues to physical conditions that help drive cell division and motility. The results may also hint at conditions that helped facilitate the original transition from inanimate to living matter.
Active droplets of filamentous material enclosed in a lipid membrane are the main cell-like characteristics modeled in a program, developed by physicists Luca Giomi and Antonio DeSimone of the International School for Advanced Studies (SISSA; Scuola Internazionale Superiore di Studi Avanzati; Trieste, Italy), for numerical simulations to investigate the mechanics of “simplified” pre-cell structures. The simulations indicated a spontaneous emergence of features reminiscent of living material—of cell-like motility and division.
The model mimics some of the physical properties of cells: “Our ‘cells’ are a bare bones representation of a biological cell, which normally contains microtubules, elongated proteins, enclosed in an essentially lipid cell membrane," said Dr. Giomi; "The filaments contained in the ‘cytoplasm’ of our cells slide over one another exerting a force that we can control." The force exerted by the filaments is the variable that competes with another force, the surface tension that prevents the membrane surrounding the droplet from collapsing. This "competition" generates a flow in the fluid surrounding the droplet, and the droplet is in turn propelled by this self-generated hydrodynamic flow. When the flow becomes very strong, the droplet deforms to the point of dividing: "When the force of the flow prevails over the force that keeps the membrane together we have ‘cellular’ division," said Dr. DeSimone, director of the SISSA mathLab, SISSA's mathematical modeling and scientific computing laboratory.
"We showed that by acting on a single physical parameter in a very simple model we can reproduce similar effects to those obtained with experimental observations," continued Dr. DeSimone. Empirical observations on microtubule specimens have shown that these also move outside the cell environment, in a manner proportional to the energy they have (derived from ATP). "Similarly, our droplets, fuelled by their ‘inner’ energy alone—without forces acting from the outside—are able to move and even divide," he said.
The study, described in the April 10, 2014, online issue of the journal Physical Review Letters, is a step forward toward creating functional artificial cells and toward a better understanding of the first passages from which life has developed: "Acquiring motility and the ability to divide is a fundamental step for life and, according to our simulations, the laws governing these phenomena could be very simple. Observations like ours can prepare the way for the creation of functioning artificial cells, and not only," said Dr. Giomi. "Our work is also useful for understanding the transition from non-living to living matter on our planet." Chemists and biologists who study the origin of life lack access to cells that are sufficiently simple. "Even the simplest organism existing today has undergone billions of years of evolution, and will always contain fairly complex structures," noted Dr. Giomi.
Related Links:
SISSA, International School for Advanced Studies
Active droplets of filamentous material enclosed in a lipid membrane are the main cell-like characteristics modeled in a program, developed by physicists Luca Giomi and Antonio DeSimone of the International School for Advanced Studies (SISSA; Scuola Internazionale Superiore di Studi Avanzati; Trieste, Italy), for numerical simulations to investigate the mechanics of “simplified” pre-cell structures. The simulations indicated a spontaneous emergence of features reminiscent of living material—of cell-like motility and division.
The model mimics some of the physical properties of cells: “Our ‘cells’ are a bare bones representation of a biological cell, which normally contains microtubules, elongated proteins, enclosed in an essentially lipid cell membrane," said Dr. Giomi; "The filaments contained in the ‘cytoplasm’ of our cells slide over one another exerting a force that we can control." The force exerted by the filaments is the variable that competes with another force, the surface tension that prevents the membrane surrounding the droplet from collapsing. This "competition" generates a flow in the fluid surrounding the droplet, and the droplet is in turn propelled by this self-generated hydrodynamic flow. When the flow becomes very strong, the droplet deforms to the point of dividing: "When the force of the flow prevails over the force that keeps the membrane together we have ‘cellular’ division," said Dr. DeSimone, director of the SISSA mathLab, SISSA's mathematical modeling and scientific computing laboratory.
"We showed that by acting on a single physical parameter in a very simple model we can reproduce similar effects to those obtained with experimental observations," continued Dr. DeSimone. Empirical observations on microtubule specimens have shown that these also move outside the cell environment, in a manner proportional to the energy they have (derived from ATP). "Similarly, our droplets, fuelled by their ‘inner’ energy alone—without forces acting from the outside—are able to move and even divide," he said.
The study, described in the April 10, 2014, online issue of the journal Physical Review Letters, is a step forward toward creating functional artificial cells and toward a better understanding of the first passages from which life has developed: "Acquiring motility and the ability to divide is a fundamental step for life and, according to our simulations, the laws governing these phenomena could be very simple. Observations like ours can prepare the way for the creation of functioning artificial cells, and not only," said Dr. Giomi. "Our work is also useful for understanding the transition from non-living to living matter on our planet." Chemists and biologists who study the origin of life lack access to cells that are sufficiently simple. "Even the simplest organism existing today has undergone billions of years of evolution, and will always contain fairly complex structures," noted Dr. Giomi.
Related Links:
SISSA, International School for Advanced Studies
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







